Pro Share Advisors LLC Reata Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$79.22 - $105.37 $29,786 - $39,619	376 Added 6.86%	5,855 $596,000
Q1 2023 May 11, 2023	SELL	$30.85 - $93.17 $21,687 - $65,498	-703 Reduced 11.37%	5,479 $498,000
Q4 2022 Feb 02, 2023	BUY	$22.15 - $42.11 $136,931 - $260,324	6,182 New	6,182 $234,000
Q2 2022 Aug 01, 2022	SELL	$20.71 - $36.5 $174,108 - $306,855	-8,407 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$24.12 - $39.6 $48,746 - $80,031	-2,021 Reduced 19.38%	8,407 $276,000
Q4 2021 Feb 08, 2022	BUY	$25.61 - $110.96 $4,865 - $21,082	190 Added 1.86%	10,428 $275,000
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $252,100 - $360,553	-2,521 Reduced 19.76%	10,238 $1.03 Million
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $662,790 - $1.28 Million	8,468 Added 197.34%	12,759 $1.81 Million
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $15,080 - $21,249	-160 Reduced 3.59%	4,291 $428,000
Q4 2020 Feb 09, 2021	SELL	$102.03 - $184.62 $15,406 - $27,877	-151 Reduced 3.28%	4,451 $550,000
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $9,540 - $16,660	102 Added 2.27%	4,602 $448,000
Q2 2020 Aug 03, 2020	SELL	$126.3 - $176.56 $77,800 - $108,760	-616 Reduced 12.04%	4,500 $702,000
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $480,747 - $959,249	-3,872 Reduced 43.08%	5,116 $738,000
Q4 2019 Feb 12, 2020	BUY	$74.57 - $217.92 $5,294 - $15,472	71 Added 0.8%	8,988 $1.84 Million
Q3 2019 Nov 12, 2019	SELL	$71.26 - $95.75 $15,178 - $20,394	-213 Reduced 2.33%	8,917 $716,000
Q2 2019 Aug 13, 2019	SELL	$77.72 - $94.35 $85,802 - $104,162	-1,104 Reduced 10.79%	9,130 $861,000
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $6,902 - $13,538	133 Added 1.32%	10,234 $875,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $90,839 - $142,407	-1,863 Reduced 15.57%	10,101 $567,000
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $49,468 - $127,779	1,388 Added 13.12%	11,964 $978,000
Q2 2018 Aug 13, 2018	SELL	$19.94 - $40.96 $897 - $1,843	-45 Reduced 0.42%	10,576 $370,000
Q1 2018 May 14, 2018	SELL	$20.0 - $30.19 $34,980 - $52,802	-1,749 Reduced 14.14%	10,621 $218,000
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $276,964 - $411,549	12,370	12,370 $350,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account